Article Listing - Brazil’s INPI wins battle against extension of Pfizer’s Lipitor patent

YUGOSLAV VACCINE PROGRAM

13 April 1992

ICN Pharmaceuticals of California and ICN-Galenika are to partly finance a project costing over $100,000 to vaccinate children in the...

GERMAN PANEL DOCTOR NUMBERS

13 April 1992

The rate of rise in the number of doctors in public-sector general practice registering in Germany is growing, says the...

SCHERING CORP TO MARKET FELBAMATE

13 April 1992

Schering Corp reports that it will have exclusive rights to market Carter-Wallace's N-methyl-D-aspartate receptor antagonist anticonvulsant felbamate worldwide, with the...

NET PROFITS UP 41% AT SYNTHELABO

13 April 1992

French health care group Synthelabo reported consolidated turnover in 1991 up 8.1% on 1990 at 3.45 billion French francs ($618.8...

STRONG EXPANSION AT KNOLL IN 1991

13 April 1992

The drug-making arm of the German chemical concern BASF, Knoll AG, has reported a 9% expansion of sales worldwide...

NOVO-NORDISK'S rec INSULIN LAUNCHED IN FRANCE

13 April 1992

Novo-Nordisk has launched four formulations of its recombinant human insulin under the trade name Mixtard HMge Penfill. All the formulations...

BIOCRAFT BOOSTED BY APPROVALS

13 April 1992

The US pharmaceutical concern Biocraft Laboratories has been boosted in the first quarter of the current year by approvals from...

IDEC PHARMA'S ANTIBODY THERAPY

13 April 1992

IDEC Pharmaceuticals reports that it has developed a "primatized" antibody which could improve the treatment of several chronic diseases. The...

S-P HEALTHCARE PRODUCTS CANADA

13 April 1992

At Schering-Plough Health-Care Products Canada Inc, George Cugini moves up to vice president, marketing, from marketing director, seasonal products. Dan...

ISRAEL'S YISSUM R&D CO CLAIMS ACHIEVEMENTS

13 April 1992

Yissum is Israel's leading university R&D company, the Marketletter's local correspondent notes, and it offers more than 150 applied research...

Showing 94311-94320 of 95360 articles